This contract involves the purchase and ongoing supply of laboratory reagents for the Pathology Laboratory and Analytical Laboratory, including the leasing of analyzers, for the Emergency Medical Service in Lębork. The supplier is responsible for transportation and assumes all costs and risks. Along
Contract awarded. Originally published 11 months ago.
No single supplier dominates the field.
In healthcare medical, INDEPENDENT PUBLIC SPECIALIZED HEALTHCARE FACILITY has awarded 4 contracts to 4 suppliers.
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
This contract involves the purchase and ongoing supply of laboratory reagents for immunohematology, immunochemistry, and immunohistochemistry testing. It includes the leasing of necessary equipment for these tests at the SPS ZOZ laboratory in Lębork, Poland. The supplier is responsible for transport
This contract involves the procurement and ongoing delivery of food products to the Independent Public Specialist Healthcare Facility in Lębork, Poland. The supplier is responsible for the transportation and associated costs and risks. A detailed list of the required food products is provided in the
This contract involves the purchase and ongoing supply of laboratory reagents for immunohematology, immunochemistry, and immunohistochemistry testing. It includes the leasing of necessary equipment for these tests at the SPS ZOZ laboratory in Lębork, Poland. The supplier is responsible for transport
NHS Scotland is seeking suppliers of generic and biosimilar cancer medicines to improve patient access and optimize healthcare costs.
Royal Borough of Greenwich is commissioning a School Health and Wellbeing Service to deliver preventative health and early intervention support for children and young people aged 5-19 years across the borough, with contract commencement in April 2027.
Suffolk County Council is testing market interest for postal delivery of nicotine replacement therapy and smoking cessation medications to improve accessibility for local residents.
PSD Scotland is engaging with the market to explore delivery solutions for a national Targeted Lung Cancer Screening Programme for smokers aged 55-74 in Scotland.
